Identification of metabolic biomarkers of chronic vagus nerve stimulation ( VNS ) in subjects with drug‐resistant epilepsy ( DRE )
Epilepsia Open · 2024-02 · 9 (1) · 432-438
DOI: 10.1002/epi4.12871 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia Open, online erschienen am 26.12.2023. Verfasst von Claudia Manca und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Division of Physiology, University of Cagliari, Cagliari, Italy. Hauptthemen laut MEDLINE: Vagus Nerve Stimulation, Drug Resistant Epilepsy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Neuromodulation by means of vagus nerve stimulation (VNS) therapy, reduces seizure frequency and improves quality of life in subjects with drug‐resistant epilepsy (DRE), yet its molecular mechanism remains unclear. This study investigates the impact of chronic VNS on lipid bioactive metabolites and fatty acids (FA) in the plasma and red blood cells of seven subjects with DRE. By measuring expression levels of peroxisome proliferator‐activated receptor α ( PPARα ) and sirtuin1 ( SIRT1 ) genes—key regulators in energy and lipid metabolism—and lipid profiles before and after various stages of VNS, this study identifies potential mechanisms by which VNS may reduce seizure frequency. Blood samples collected before VNS device implantation, after acute VNS stimulus, and following gradual intensity increments up to therapeutic levels revealed that VNS increases SIRT1 and PPARα expression and erythrocyte concentrations of PPARα ligands. Additionally, we observe reduced de novo lipogenesis biomarkers in erythrocytes, indicating that VNS may influence systemic lipid and energy metabolism. Our findings suggest that VNS could enhance neuronal function by modulating energy metabolism, thus potentially reducing seizure frequency in subjects with DRE. Future research targeting SIRT1 and PPARα may provide innovative therapeutic strategies for managing DRE. Plain Language Summary: The exact mechanism of VNS is still unknown. This study investigated the effects of VNS Therapy on energetic metabolism, suggesting possible novel biomarkers for DRE subjects and neuromodulation therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Division of Physiology, University of Cagliari, Cagliari, Italy.
- Center for the Diagnosis and Treatment of Adult Epilepsy, Neurology Unit, AOU Cagliari, Cagliari, Italy.
- SC Neurosurgery, Neuroscience and Rehabilitation Department, San Michele Hospital, ARNAS G. Brotzu, Cagliari, Italy.
- SC Vascular Surgery, AOU Cagliari, Cagliari, Italy.
- Department of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.
- Neuroscience Institute, National Research Council of Italy (CNR), Section of Cagliari, Cagliari, Italy.
ORCID-Profile: Claudia Manca, Roberta Coa
Zitieren
APA
Manca, C., Coa, R., Murru, E., Carta, G., Pinna, G., Sanfilippo, R., Polizzi, L., Pistis, M., Follesa, P., Puligheddu, M., & Banni, S. (2024). Identification of metabolic biomarkers of chronic vagus nerve stimulation ( VNS ) in subjects with drug‐resistant epilepsy ( DRE ). Epilepsia Open, 9(1), 432-438. https://doi.org/10.1002/epi4.12871
Vancouver
Manca C, Coa R, Murru E, Carta G, Pinna G, Sanfilippo R, et al. Identification of metabolic biomarkers of chronic vagus nerve stimulation ( VNS ) in subjects with drug‐resistant epilepsy ( DRE ). Epilepsia Open. 2024;9(1):432-438. doi:10.1002/epi4.12871
BibTeX
@article{Manca2024,
author = {Manca, Claudia and Coa, Roberta and Murru, Elisabetta and Carta, Gianfranca and Pinna, Giovanni and Sanfilippo, Roberto and Polizzi, Lorenzo and Pistis, Marco and Follesa, Paolo and Puligheddu, Monica and Banni, Sebastiano},
title = {Identification of metabolic biomarkers of chronic vagus nerve stimulation ( VNS ) in subjects with drug‐resistant epilepsy ( DRE )},
journal = {Epilepsia Open},
year = {2024},
volume = {9},
number = {1},
pages = {432--438},
doi = {10.1002/epi4.12871}
}
EUVIMED